Thursday, August 23, 2012

Liraglutide Results in Decreased BMI and Waist Circumference

So do fewer Calories in than out.
A decrease in waist circumference in patients with type 2 diabetes treated with liraglutide correlates with positive alterations in inflammatory markers, according to data presented here at the 3rd International Congress on Abdominal Obesity (ICAO).
Fewer Calories are cheaper and without side effects, e.g., drug interactions.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.